Order Article Reprints

Wang X, Chen G, Nie L, Wu Z, Wang X, Pan C, Chen X, Zhao X, Zhu J, He Q, et al. IL-2K35C-moFA, a Long-Acting Engineered Cytokine with Decreased Interleukin 2 Receptor α Binding, Improved the Cellular Selectivity Profile and Antitumor Efficacy in a Mouse Tumor Model. Cancers. 2022; 14(19):4742. https://doi.org/10.3390/cancers14194742

Wang, Xiaoze, Gang Chen, Lei Nie, Zhenhua Wu, Xinzeng Wang, Chenxiao Pan, Xuchen Chen, Xiaobei Zhao, Jie Zhu, Qiaojun He, and et al. 2022. "IL-2K35C-moFA, a Long-Acting Engineered Cytokine with Decreased Interleukin 2 Receptor α Binding, Improved the Cellular Selectivity Profile and Antitumor Efficacy in a Mouse Tumor Model" Cancers 14, no. 19: 4742. https://doi.org/10.3390/cancers14194742

Wang, X., Chen, G., Nie, L., Wu, Z., Wang, X., Pan, C., Chen, X., Zhao, X., Zhu, J., He, Q., & Wang, H. (2022). IL-2K35C-moFA, a Long-Acting Engineered Cytokine with Decreased Interleukin 2 Receptor α Binding, Improved the Cellular Selectivity Profile and Antitumor Efficacy in a Mouse Tumor Model. Cancers, 14(19), 4742. https://doi.org/10.3390/cancers14194742